Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Famotidine in Esophageal and Cardia Cancer
IRCT20170728035349N1Phase 3Completed
- Sponsor
- Zanjan University of Medical Sciences
- Start
- Sep 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of famotidine in esophageal cancer and gastric cardia cancer (GEJ), sponsored by Zanjan University of Medical Sciences. Started Sep 2020; status: completed.
02
Drugs
famotidine
03
Conditions
esophageal cancergastric cardia cancer (GEJ)
Beyond the preview
Go deeper on IRCT20170728035349N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20170728035349N1.